Takeharu Kakiuchi Selected Research

Takeharu Kakiuchi Research Topics

Disease

5	Parkinson Disease (Parkinson's Disease) 01/2017 - 11/2006
4	Neuroinflammatory Diseases 11/2019 - 04/2014
4	Neoplasms (Cancer) 02/2009 - 01/2002
3	Ischemia 04/2014 - 01/2002
2	Brain Ischemia (Cerebral Ischemia) 04/2017 - 11/2006
2	Infarction (Infarctions) 01/2017 - 11/2006
2	Stroke (Strokes) 01/2017 - 11/2005
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 04/2014 - 11/2006
1	Cognitive Dysfunction 12/2021
1	Brain Diseases (Brain Disorder) 12/2021
1	Alzheimer Disease (Alzheimer's Disease) 10/2020
1	Fibrosis (Cirrhosis) 07/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 07/2018
1	Brain Neoplasms (Brain Tumor) 06/2018
1	Reperfusion Injury 04/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2009
1	Overactive Urinary Bladder (Overactive Bladder) 06/2008
1	Hypothermia 01/2006
1	Neoplasm Metastasis (Metastasis) 01/2002

Drug/Important Bio-Agent (IBA)

4	Dopamine (Intropin)FDA LinkGeneric 01/2016 - 08/2004
3	Oxygen (Dioxygen)IBA 04/2017 - 11/2006
3	LigandsIBA 02/2009 - 01/2002
2	Amyloid (Amyloid Fibrils)IBA 12/2021 - 11/2014
2	Glucose (Dextrose)FDA LinkGeneric 10/2020 - 11/2014
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 11/2019 - 01/2017
2	Tyrosine (L-Tyrosine)FDA Link 06/2018 - 04/2006
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2017 - 01/2016
2	2- tert- butyl- 4- chloro- 5- (6- (2- (2- fluoroethoxy)ethoxy)pyridin- 3- ylmethoxy)- 2H- pyridazin- 3- oneIBA 01/2016 - 04/2014
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2009 - 10/2004
2	alovudineIBA 02/2009 - 10/2004
2	Neuroprotective AgentsIBA 11/2006 - 11/2005
1	Adenosine Triphosphate (ATP)IBA 12/2021
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 12/2021
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2021
1	2- tert- butyl- 4- chloro- 5- (6- (4- fluorobutoxy)pyridin- 3- ylmethoxy)- 2H- pyridazin- 3- oneIBA 07/2018
1	Eosine Yellowish-(YS) (Eosin)IBA 07/2018
1	liposome-encapsulated hemoglobinIBA 04/2017
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2017
1	2- oxo- 7- methoxy- 8- butyloxy- 1,2- dihydroquinoline- 3- carboxylic acid cyclohexylamideIBA 01/2017
1	fluorodopa F 18IBA 02/2016
1	Muscarinic AntagonistsIBA 06/2008
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 06/2008
1	Epoprostenol ReceptorsIBA 11/2006
1	Amino Acids FDA Link 04/2006
1	Propofol (Diprivan)FDA LinkGeneric 01/2006
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 11/2005
1	TRA418IBA 11/2005
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 10/2004
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2004
1	Adenosine (Adenocard)FDA LinkGeneric 08/2004
1	Serotonin (5 Hydroxytryptamine)IBA 08/2004
1	Cholinergic Agents (Cholinergics)IBA 01/2002
1	IntegrinsIBA 01/2002
1	VitronectinIBA 01/2002
1	GABA-A Receptors (GABA(A) Receptor)IBA 01/2002
1	Cholinergic ReceptorsIBA 01/2002
1	Integrin alphaVIBA 01/2002
1	N-methyl-3-piperidyl benzilateIBA 01/2002

Therapy/Procedure

2	Radiotherapy 02/2009 - 10/2004
1	Therapeutics 07/2009
1	Transplantation 07/2009
1	Anesthesia 01/2006
1	Photochemotherapy (Photodynamic Therapy) 10/2004